
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today the Company …